Intra-Cellular Therapies Reports First Quarter 2020 Financial Results and Provides Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. CBRS
3. FDX
4. USO
5. MU
6. SPY
7. KBH
8. HTZ
9. HON
10. JPM

Go back to Intra-Cellular Therapies Reports First Quarter 2020 Financial Results and Provides Corporate Update

Intra-Cellular Therapies (ITCI) Tops Q1 EPS by 20c, Revenues Miss

May 7, 2020 7:58 AM EDT

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q1 EPS of ($0.73), $0.20 better than the analyst estimate of ($0.93). Revenue for the quarter came in at $1.08 million versus the consensus estimate of $1.44 million.

In the midst of these unprecedented times we are proud of the agile adaptation of our... More